1.Janiel Pimentel, Chirag Kapadia, Dorothee Newbern and Gabriel Shaibi. Adrenal Suppression Secondary to Interaction of Combined Inhaled Corticosteroid and Antifungal Agent. AACE Clin Case Rep. Jul 2018, Vol. 4, No. 4 (July/August 2018) pp. e305-e308.2.Melissa A. Chambers, Theresa A. Grebe, and Dorothee K.D. Newbern. Two cases of 22q11 Deletion Syndrome and Type 1 Diabetes. AACE Clin Case Rep. May 2018, Vol. 4, No. 3 (May/June 2018) pp. e209-e212.3.Gkourogianni A, Andrew M, Tyzinski L, Crocker M, Douglas J, Dunbar N, Fairchild J, Funari MF, Heath KE, Jorge AA, Kurtzman T, LaFranchi S, Lalani S, Lebl J, Lin Y, Los E, Newbern D, Nowak C, Olson M, Popovic J, Pruhova S, Elblova L, Quintos JB, Segerlund E, Sentchordi L, Shinawi M, Stattin EL, Swartz J, Ariadna GA, Sinhue DC, Hosono H, Sanchez-Lara PA, Hwa V, Baron J, Nilsson O, Dauber A. Clinical characterization of patients with autosomal dominant short stature due to aggrecan mutations. J Clin Endocrinol Metab. 2017 February, 102(2):460-469.4.Hinson A, Newbern D, Linardic C. Asparaginase-Induced Hypertriglyceridemia Presenting as Pseudohyponatremia during Leukemia Treatment. Case Rep Pediatr. 2014; 2014: 635740.5.Newbern D, Gumus-Balikcioglu P, et. al. Sex Differences in Biomarkers Associated with Insulin Resistance in Obese Adolescents: Metabolic Profiling and Principal Component Analysis. J Clin Endocrinol Metab. 2014 Dec; 99(12):4730-9.6.Irizarry K, Newbern D, Freemark M. Chapter 19: Endocrinopathies of the Preterm Infant. William F. Malcolm, ed. Beyond the NICU: Comprehensive Care of the High Risk Infant. New York, NY, August 2014: The McGraw-Hill Companies.7.Newbern D, Freemark M. Placental hormones and the control of maternal metabolism and fetal growth. Curr Opin Endocrinol Diabetes Obes. 2011 Dec;18(6):409-16. Review.8.Newbern, D.K. A neonate with autosomal recessive pseudohypoaldosteronism type 1. Endo Trends, 2010; 17 (1): 7-9.